# RemeGen Co., Ltd. > Legal entity — legal form ECAK, registered in CN **Wikidata**: [Q106302019](https://www.wikidata.org/wiki/Q106302019) **Source**: https://4ort.xyz/entity/remegen-co-ltd ## Summary RemeGen Co., Ltd. is a public company operating within the pharmaceutical industry, headquartered in Yantai. It is a joint-stock corporation that offers its securities to the general public, distinguishing it from private enterprises or government agencies. The entity is also known by the alias "荣昌生物" and maintains an official website at http://www.remegen.com. ## Key Facts * **Entity Classification:** RemeGen Co., Ltd. is a public company, a specific legal form of organization and a type of joint-stock company. * **Industry Sector:** The company operates exclusively within the pharmaceutical industry. * **Headquarters Location:** The corporate headquarters are located in Yantai. * **Official Alias:** The entity is identified by the Chinese alias "荣昌生物". * **Digital Presence:** The company's official website is http://www.remegen.com, with content available in English. * **Unique Identifiers:** The entity is assigned the Google Knowledge Graph ID `/g/11lglj062h` and the Crunchbase Organization ID `remegen`. * **Ownership Structure:** As a public company, its ownership is distributed among general public shareholders rather than a closed group of private investors. ## FAQs **What type of business entity is RemeGen Co., Ltd.?** RemeGen Co., Ltd. is classified as a public company, meaning it is a joint-stock organization that offers its securities, such as stocks or bonds, for sale to the general public. This structure allows it to raise capital from a wide pool of investors through public markets, distinguishing it from private companies or state-owned public enterprises. **Where is RemeGen Co., Ltd. based and how can it be contacted?** The company is headquartered in Yantai and maintains a digital presence through its official website at http://www.remegen.com. The website content is available in English, serving as a primary channel for public information and corporate communication. **How is RemeGen Co., Ltd. identified in global databases?** The entity is uniquely tracked in major data repositories using specific identifiers, including the Google Knowledge Graph ID `/g/11lglj062h` and the Crunchbase Organization ID `remegen`. These IDs ensure accurate distinction from other organizations in financial and academic research contexts. ## Why It Matters RemeGen Co., Ltd. represents a fundamental pillar of modern capitalism within the pharmaceutical sector, enabling large-scale capital formation necessary for business expansion and medical innovation. By operating as a public company, it provides liquidity for investors, allowing individuals and institutions to easily buy and sell ownership stakes in a high-impact industry. Its structure promotes transparency through strict regulatory disclosure and reporting standards, which fosters trust among the general public and drives economic growth in the healthcare field. ## Notable For * Being a publicly traded entity within the competitive pharmaceutical industry. * Operating under the distinct Chinese alias "荣昌生物" while maintaining an international corporate identity. * Maintaining a verified digital footprint with a dedicated English-language website. * Holding specific, verifiable identifiers in global knowledge graphs and business databases. * Functioning as a joint-stock company with a clear separation of ownership and control. ## Body ### Definition and Corporate Structure RemeGen Co., Ltd. is defined by its status as a public company, a legal form of organization that allows it to raise capital by offering securities to the general public. This classification places it within the broader category of joint-stock companies and distinguishes it from private enterprises that raise funds from closed groups of investors. The company's structure facilitates the separation of ownership, held by public shareholders, and control, managed by a board of directors. This model is a specific type of enterprise that is distinct from government agencies or cooperatives. ### Industry and Operational Scope The entity operates specifically within the pharmaceutical industry, a sector critical to global health and economic development. As a public company in this field, RemeGen Co., Ltd. is subject to rigorous regulatory disclosure and reporting standards designed to ensure transparency for investors and the public. Its operations contribute to the broader ecosystem of large-scale business operations found in developed economies, focusing on the creation of value through medical innovation and infrastructure projects. ### Geographic and Digital Presence Headquartered in Yantai, the company anchors its operations in a specific geographic location while maintaining a global digital reach. Its official website, http://www.remegen.com, serves as a primary information hub, with content specifically curated in English to facilitate international engagement. This digital presence supports its role as a publicly traded entity, providing necessary disclosures and corporate updates to a global audience of potential and current shareholders. ### Identification and Data Integration To ensure accurate recognition across various data ecosystems, RemeGen Co., Ltd. is assigned unique identifiers that link its physical and legal existence to digital records. The Google Knowledge Graph ID `/g/11lglj062h` and the Crunchbase Organization ID `remegen` serve as definitive references for the entity in financial and academic resources. These identifiers allow the company to be distinguished from similarly named organizations and ensure its inclusion in datasets covering economics, econometrics, and finance. ### Terminology and Global Recognition The entity is recognized by the alias "荣昌生物," reflecting its identity in Chinese-speaking markets. This dual naming convention highlights its presence in both local and international contexts. The concept of the public company, which RemeGen embodies, is a globally recognized topic discussed in numerous languages and covered in major financial resources like Investopedia and academic platforms like ScienceDirect. This global recognition underscores the universal applicability of the public company model in driving investment and economic activity.